Resources

 The latest in cell & gene research, from advanced therapies through to the latest developments in cell & gene research, therapies & manufacturing

Cell & Gene Therapy Manufacturing

Innovative Financial Strategies in Gene Therapy: A Shift Towards Sustainable Access

Discover the key strategies and financial nuances of gene therapy like outcome-driven contracts, payment plans, and shared financial agreements
Cell & Gene Therapy Manufacturing

Sustainability in Cell Therapy Manufacture: Improving Process Efficiency for Cell Line Development

Improving process efficiency is a key approach to factor in when looking at how cell therapy manufacture can be made more sustainable.
Cell & Gene Therapy Manufacturing

CAR T-REX Aims to Bolster Anti-Tumoural Immune Response

An international European consortium has received a €2.7m grant to improve the safety and effectiveness of CAR-T cell therapies for solid tumours. If successful, the grant could massively improve treatment outcomes for patients.
Cell & Gene Therapy Manufacturing

Crossing the Pond: Key Considerations for Stateside Biotechs Looking to the UK and Europe

Among the challenges faced by US biotechs looking at setting up in Europe, regulatory and cultural differences are chief among them. However, the strong tradition of scientific research and high standard of medical care across the Atlantic makes it worth the effort.
Cell & Gene Therapy Manufacturing

Healthcare Data Platforms: Expert Tips on Integrating Digitalisation with Cell and Gene Manufacturing

Developers looking to integrate digitalisation approaches into their pipeline should ensure that they choose a sensible architecture, rather than simply automating for the sake of it.
Cell & Gene Therapy Manufacturing

Metabolic Modelling and Machine Learning Technologies in Cell and Gene Manufacturing

Integrating PAT into metabolic modelling can help optimise the product obtained from cell cultures, augmenting the manufacturing process.
Cell & Gene Therapy Manufacturing

Cell and Gene Manufacturing Approaches and Winning Strategies for Commercialisation and Scale-Up

With a host of factors to consider in cell and gene manufacture, upscaling is still no small task. However, as industry experience accumulates and new technologies arrive on the market, there are an increasing number of options for developers looking to get their therapeutic on the road to the clinic.
Cell & Gene Therapy Manufacturing

AI in Gene Therapy: How Could Machine Learning Approaches Reshape Therapeutic Development?

As more developers bring their cell and gene therapy products to industry regulators, the need to drive cost and process efficiencies is on track to keep growing. Across the board, AI and machine learning approaches have the potential to streamline many aspects of development.
Cell & Gene Therapy Manufacturing

Industry Insights Into the FDA's Plans for Revised Gene Therapy Approval Approaches

Some additional measures announced include the launch of the Cell and Gene Therapy Access Model, as well as the interpolation of RWE into trials and a potential move away from animal models in validating treatment efficacy.
Cell & Gene Therapy Manufacturing

Q &A with Shilpi Rajoria

An interview Shilpi Rajoria, Director QC Analytical Testing at Bristol Myers Squibb.

Subscribe to Our Newsletter

Sign up for our monthly newsletter to
keep up with all things cell & gene